Sumithran P, Prendergast LA, Delbridge E, et al
Although primarily indicated for diabetes management, it has shown promising results in clinical trials for weight loss in obese or overweight individuals
In addition, intensive research focused on biological targets which could stimulate GLP-1 release in the gut or pancreas, including GPR120, SSTR5, GPR40, TGR-5 and GPR119
That being said, SkinnyRx is a strong option, but it is not the only one
This method ensures that a higher percentage of the active substance is available for the body to use, potentially offering quicker and more potent effects
Bottom line: For active weight loss, staying on a weekly scheduleeven at a lower doseis significantly more effective than spacing a higher dose out to every two weeks